Nanomaterials for Delivery of Drugs and Genes to Disrupt Notch Signaling Pathway in Breast Cancer

The authors examine recent breakthroughs in nanocarrier systems aimed at the Notch signaling pathway in breast cancer, highlighting the therapeutic potential of integrating nanomedicine with Notch inhibition to disrupt epithelial-mesenchymal transition, tumor-initiating cells, and metastasis, thereby enhancing clinical outcomes.